Drug
GNbAC1
GNbAC1 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
3
50%
Ph phase_1
3
50%
Phase Distribution
3
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 2Efficacy & side effects
3(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 13 (50.0%)
Phase 23 (50.0%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_2
Safety Study of GNbAC1 in Multiple Sclerosis Patients
NCT01639300
completedphase_2
Clinical Trial Assessing the GNbAC1 in Patients With Onset of Type 1 Diabetes Within 4 Years
NCT03179423
completedphase_1
Single Ascending Doses Study With GNbAC1 in Healthy Male Volunteers
NCT03574428
completedphase_2
Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MS
NCT02782858
completedphase_1
First-in-Human Study With GNbAC1 in Healthy Volunteers
NCT01699555
Clinical Trials (6)
Showing 6 of 6 trials
NCT01639300Phase 2
Safety Study of GNbAC1 in Multiple Sclerosis Patients
NCT03179423Phase 2
Clinical Trial Assessing the GNbAC1 in Patients With Onset of Type 1 Diabetes Within 4 Years
NCT03574428Phase 1
Single Ascending Doses Study With GNbAC1 in Healthy Male Volunteers
NCT02782858Phase 2
Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MS
NCT01699555Phase 1
First-in-Human Study With GNbAC1 in Healthy Volunteers
NCT02452996Phase 1
Safety Study of GNbAC1 Monoclonal Antibody in Healthy Male Volunteers
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6